DE69333610D1 - Methoden für die immunoempfängnisverhütung - Google Patents

Methoden für die immunoempfängnisverhütung

Info

Publication number
DE69333610D1
DE69333610D1 DE69333610T DE69333610T DE69333610D1 DE 69333610 D1 DE69333610 D1 DE 69333610D1 DE 69333610 T DE69333610 T DE 69333610T DE 69333610 T DE69333610 T DE 69333610T DE 69333610 D1 DE69333610 D1 DE 69333610D1
Authority
DE
Germany
Prior art keywords
zona pellucida
methods
immune prevention
proteins
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69333610T
Other languages
English (en)
Inventor
Jeffrey D Harris
Kuang T Hsu
Joseph S Podolski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repros Therapeutics Inc
Original Assignee
Zonagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zonagen Inc filed Critical Zonagen Inc
Application granted granted Critical
Publication of DE69333610D1 publication Critical patent/DE69333610D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
DE69333610T 1992-11-09 1993-11-06 Methoden für die immunoempfängnisverhütung Expired - Lifetime DE69333610D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97334192A 1992-11-09 1992-11-09
US1299093A 1993-01-29 1993-01-29
PCT/US1993/010851 WO1994011019A1 (en) 1992-11-09 1993-11-06 Materials and methods for immunocontraception

Publications (1)

Publication Number Publication Date
DE69333610D1 true DE69333610D1 (de) 2004-10-07

Family

ID=32965094

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333610T Expired - Lifetime DE69333610D1 (de) 1992-11-09 1993-11-06 Methoden für die immunoempfängnisverhütung

Country Status (9)

Country Link
US (5) US6027727A (de)
EP (1) EP0634936B1 (de)
JP (1) JPH07503142A (de)
CN (1) CN1110177A (de)
AT (1) ATE275191T1 (de)
AU (1) AU675269B2 (de)
CA (1) CA2127531A1 (de)
DE (1) DE69333610D1 (de)
WO (1) WO1994011019A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE37224E1 (en) * 1992-06-05 2001-06-12 Dalhousie University Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
WO1999034825A1 (en) * 1998-01-02 1999-07-15 The University Of Georgia Research Foundation, Inc. Fertility impairing vaccine and method of use
US7037663B2 (en) * 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
EP1056858B1 (de) * 1998-02-19 2004-12-08 Eastern Virginia Medical School Rekombinantes aktives humänes zona pellucida protein 3 (hzp3)
US6455041B1 (en) * 1998-11-17 2002-09-24 Bonita S. Dunbar Immunogenic epitopes of the human zona pellucida protein (ZP1)
AU3962700A (en) 1999-03-17 2000-10-04 Biosyn Arzneimittel Gmbh Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin
DE19939578A1 (de) 1999-08-20 2001-02-22 Biosyn Arzneimittel Gmbh Nukleinsäuremolekül, umfassend eine für ein Hämocyanin kodierende Nukleinsäuresequenz
WO2001090185A2 (en) * 2000-05-25 2001-11-29 Queen's University At Kingston Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
JP4744062B2 (ja) * 2000-10-18 2011-08-10 アメリカ合衆国 生殖能力に不可欠なヒト遺伝子
EP1421104A4 (de) * 2001-08-02 2005-08-24 Trinity Biomedical Technology Humane zona-pellucida-proteine und verfahren zu deren verwendung bei der diagnose männlicher unfruchtbarkeit
US20030181409A1 (en) * 2001-12-14 2003-09-25 The Regents Of The University Of California Methods of inhibiting fertility
US7056515B2 (en) 2002-02-08 2006-06-06 Immunovaccine Technologies Inc. Antigens for immunocontraception
EP1474447A2 (de) * 2002-02-08 2004-11-10 Immunovaccine Technologies Inc. Antigene zur immuno-schwangerschaftsverhütung
EP1606391B1 (de) * 2003-03-14 2011-01-19 Regents of the University of California Virulentes systemisches felines calicivirus
US7309495B2 (en) * 2003-03-14 2007-12-18 The Regents Of The University Of California Hemorrhagic feline calicivirus
US7639629B2 (en) * 2006-07-28 2009-12-29 Microsoft Corporation Security model for application and trading partner integration
US20080187549A1 (en) * 2007-02-07 2008-08-07 Morey William A Polyantigenic-based (multiple antigens) modi or set of methods for developing infertility vaccines
US20090090367A1 (en) * 2007-10-03 2009-04-09 Hurley Scott B Method of contraception
CN102159240B (zh) * 2008-09-17 2014-12-24 美国政府健康及人类服务部，疾病控制和预防中心 基于狂犬病毒的重组免疫避孕组合物及其使用方法
CN107158373B (zh) * 2017-05-25 2021-06-11 新疆大学 阿魏菇多糖在制备犬透明带3dna疫苗佐剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996297A (en) * 1987-10-07 1991-02-26 Zonagen, Inc. Recombinantly expressed rabbit zona pellucida polypeptides
EP0477226A4 (en) * 1989-06-12 1992-09-30 Us Health Contraceptive vaccine based on cloned zona pellucida gene
US5641487A (en) * 1989-06-12 1997-06-24 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
CA2090486A1 (en) * 1990-08-27 1992-02-28 Marcel Van Duin Human zona pellucida protein zp3
JPH05317050A (ja) * 1992-01-10 1993-12-03 Shinzou Isojima Ｐｚｐ−４遺伝子及び避妊ワクチン
AU3611793A (en) * 1992-02-04 1993-09-01 Colorado State University Research Foundation Composition and method to prevent conception or to cause sterility in animals

Also Published As

Publication number Publication date
US5981228A (en) 1999-11-09
AU675269B2 (en) 1997-01-30
AU5680094A (en) 1994-06-08
US5989550A (en) 1999-11-23
JPH07503142A (ja) 1995-04-06
US6027727A (en) 2000-02-22
CN1110177A (zh) 1995-10-18
US5976545A (en) 1999-11-02
ATE275191T1 (de) 2004-09-15
CA2127531A1 (en) 1994-05-26
EP0634936A1 (de) 1995-01-25
WO1994011019A1 (en) 1994-05-26
US5837497A (en) 1998-11-17
EP0634936B1 (de) 2004-09-01
EP0634936A4 (de) 1998-07-15

Similar Documents

Publication Publication Date Title
DE69333610D1 (de) Methoden für die immunoempfängnisverhütung
FI932678A0 (fi) Pao alfavirus baserande DNA expressionssystem
CO4700344A1 (es) Vacuna polinucleotidica para bovinos por via intradermica
NO960839L (no) Bakterieeksporterte proteiner og acellulære vaksiner som er basert på disse
DK0663010T3 (da) Fremgangsmåde til forøgelse af sekretion af overudtrykte proteiner
CH0229046H1 (de) Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech
NZ316787A (en) Methods and compositions for the selective modification of nucleic acids
DK2295065T3 (da) Modificeret varmechockprotein-antigenpeptidkompleks
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
DE3650135D1 (de) Proteingewinnung.
ES2151506T3 (es) Moleculas de adn recombinante que codifican enzimas aminopeptidasa y su uso en la preparacion de vacunas contra infecciones por helmintos.
ATE384787T1 (de) Tripeptidyl-aminopeptidase
FI852956A0 (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
FI20070041A (fi) Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
EP0395706A4 (en) Production of gonorrheal pi proteins and vaccines
DE69010096D1 (de) Expression und Sekretion von reifem menschlichem beta-Interleukin-1 in Bacillus subtilis und Mittel und Verfahren zu deren Ausführung.
ES2031438T3 (es) Metodo para la purificacion de proteinas.
DE69734586D1 (de) Retinoid-metabolisierendes protein
DK0941241T3 (da) Bordetella-stamme, som udtrykker hybridet FHA
PT95789A (pt) Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis
DE69739880D1 (de) NUKLEINSÄURELIGANDEN MIT HOHER AFFINITÄT FÜR DAS C1q PROTEIN DES KOMPLEMENTSYSTEMS
ATE201448T1 (de) Impfstoffe auf der basis von streptokinase
IT1317849B1 (it) Mezzi e metodi per l'espressione di proteine omologhe ed eterologhe inceppi di rhodococcus.
IL88622A0 (en) Dna sequences which code for an antigenic protein,antigens coded for by said dna sequences and a vaccine and method for protecting birds using the same
PT85546A (en) Protein protease inhibitors from straptomyces

Legal Events

Date Code Title Description
8332 No legal effect for de